Ablevia biotech GmbH

Injectable peptide-based decoy biotherapeutics that selectively and rapidly remove harmful circulating antibodies from blood. Adaptable to neutralize vector-specific antibodies in gene therapy and anti-drug antibodies in enzyme/factor replacement therapies (e.g., glycogen storage diseases, hemophilia).
Load...
Load...
Load...
Load...
Load...
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...

Insights

Loading Insights...
Q1/2040}
Loading Insight content to display...
Loading Insights...
Q1/2040}
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...

Funding

Workforce

Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
Loading